Patent · US Active

Alkylamido compounds and uses thereof

US10137101B2 · kind B2 · utility

6Cited by

45References

6Claims

0Family size

Assignee

Nogra Pharma Limited · IE

Inventors

Sergio Baroni · Rossera, IT
Salvatore Bellinvia · Balerna, CH
Francesca Viti · Salorino, CH

Key dates

Filing date	Oct 28, 2016
Grant date	Nov 27, 2018
Priority date	—
Expiry date	Oct 28, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2800/78
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.